Ocular inflammatory reactions have been described in patients on bisphosphonate
treatment. We estimated the incidence rate of ocular inflammation at 3 and 12 months in …

Inflammatory eye reactions (IERs) are rare but have been associated with medications to
treat osteoporosis. The aim of this review is to summarize the current literature on the …

Background: There have been several published reports of inflammatory ocular adverse
events, mainly uveitis and scleritis, among patients taking oral bisphosphonates. We …

Discussion Cases of ocular inflammation in patients taking bisphosphonates have been
reported since the early 1990s. 5, 6 Cases have involved both nitrogen and non-nitrogen …

In rare cases, bisphosphonates are well established to cause ocular inflammation,
presenting as uveitis, episcleritis, scleritis, orbital inflammation, and/or conjunctivitis. Some …

Purpose: Uveitis and scleritis are the most serious ocular side effects of bisphosphonate
therapy. The purpose of this study was to determine the 6-month rates of uveitis/scleritis …

Bisphosphonate infusions are associated with adverse events in approximately a third of
patients. Ocular complications are rare and even more so, inflammatory orbital disease …

Bisphosphonates are used to inhibit bone resorption in postmenopausal women and in the
management of hypercalcemia of malignancy. Recently, some drugs within this class of …

To report two cases of bisphosphonate-induced orbital inflammation, discuss the clinic-
radiological features and management options, and highlight the increasing frequency of an …

Introduction: To present a series of patients with bisphosphonate induced orbital
inflammation, and to review the clinical presentation, radiological features, treatment options …